Clinical Trials Browser

Phase 3 × Glioblastoma × Radiotherapy, Intensity-Modulated × Clear all

NCT04829097 2021-04-02

Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma

Phase 3 Unknown

Glioblastoma

NCT00884741 2019-07-24

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Phase 3 Completed

637 enrolled 11 charts

Glioblastoma, Gliosarcoma